JP2005534752A5 - - Google Patents

Download PDF

Info

Publication number
JP2005534752A5
JP2005534752A5 JP2004525093A JP2004525093A JP2005534752A5 JP 2005534752 A5 JP2005534752 A5 JP 2005534752A5 JP 2004525093 A JP2004525093 A JP 2004525093A JP 2004525093 A JP2004525093 A JP 2004525093A JP 2005534752 A5 JP2005534752 A5 JP 2005534752A5
Authority
JP
Japan
Prior art keywords
antibody
antigen
galnac
binding fragment
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004525093A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005534752A (ja
JP4718174B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2003/001156 external-priority patent/WO2004013151A2/en
Publication of JP2005534752A publication Critical patent/JP2005534752A/ja
Publication of JP2005534752A5 publication Critical patent/JP2005534752A5/ja
Application granted granted Critical
Publication of JP4718174B2 publication Critical patent/JP4718174B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

JP2004525093A 2002-08-01 2003-07-30 カンピロバクターグリカンおよびグリコペプチド Expired - Fee Related JP4718174B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39973502P 2002-08-01 2002-08-01
US60/399,735 2002-08-01
PCT/CA2003/001156 WO2004013151A2 (en) 2002-08-01 2003-07-30 Campylobacter glycans and glycopeptides

Publications (3)

Publication Number Publication Date
JP2005534752A JP2005534752A (ja) 2005-11-17
JP2005534752A5 true JP2005534752A5 (https=) 2006-09-07
JP4718174B2 JP4718174B2 (ja) 2011-07-06

Family

ID=31495764

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004525093A Expired - Fee Related JP4718174B2 (ja) 2002-08-01 2003-07-30 カンピロバクターグリカンおよびグリコペプチド

Country Status (9)

Country Link
US (1) US7598354B2 (https=)
EP (1) EP1527080B1 (https=)
JP (1) JP4718174B2 (https=)
CN (1) CN1671722A (https=)
AU (1) AU2003254665C1 (https=)
BR (1) BR0312896A (https=)
CA (1) CA2494223C (https=)
ES (1) ES2391525T3 (https=)
WO (1) WO2004013151A2 (https=)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7214660B2 (en) * 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
IL163806A0 (en) 2002-03-07 2005-12-18 Eidgenoess Tech Hochschule System and method for the production of recombinant glycosylated proteins in a prokaryotic host
AU2002952121A0 (en) * 2002-10-17 2002-10-31 Alchemia Limited Novel carbohydrate based anti-bacterials
PL1615945T3 (pl) 2003-04-09 2012-03-30 Ratiopharm Gmbh Sposoby glikopegylacji i białka/peptydy wytwarzane tymi sposobami
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US8633157B2 (en) 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
JP2007515410A (ja) * 2003-12-03 2007-06-14 ネオス テクノロジーズ インコーポレイテッド GlycoPEG化卵胞刺激ホルモン
US20080300173A1 (en) 2004-07-13 2008-12-04 Defrees Shawn Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
WO2006050247A2 (en) 2004-10-29 2006-05-11 Neose Technologies, Inc. Remodeling and glycopegylation of fibroblast growth factor (fgf)
US9029331B2 (en) 2005-01-10 2015-05-12 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
WO2006121569A2 (en) 2005-04-08 2006-11-16 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
ES2353814T3 (es) * 2005-05-11 2011-03-07 Eth Zuerich Proteinas n-glicosiladas recombinantes de celulas procariotas.
US20070105755A1 (en) * 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
WO2007056191A2 (en) 2005-11-03 2007-05-18 Neose Technologies, Inc. Nucleotide sugar purification using membranes
EP2049144B8 (en) 2006-07-21 2015-02-18 ratiopharm GmbH Glycosylation of peptides via o-linked glycosylation sequences
EP2054521A4 (en) 2006-10-03 2012-12-19 Novo Nordisk As PROCESS FOR CLEANING POLYPEPTIDE CONJUGATES
HRP20130382T1 (hr) 2007-04-03 2013-05-31 Biogenerix Ag Postupci lijeäśenja pomoä†u glikopegiliranog g-csf
CA2690611C (en) 2007-06-12 2015-12-08 Novo Nordisk A/S Improved process for the production of nucleotide sugars
CN107119095B (zh) 2008-01-03 2022-07-05 康乃尔研究基金会有限公司 原核生物中的糖基化蛋白表达
CA2711503A1 (en) * 2008-01-08 2009-07-16 Biogenerix Ag Glycoconjugation of polypeptides using oligosaccharyltransferases
CN101983070B (zh) 2008-02-20 2016-03-30 格林考瓦因有限公司 由来源于原核细胞的重组n-糖基化蛋白制备生物共轭物
PL2257311T3 (pl) 2008-02-27 2014-09-30 Novo Nordisk As Koniugaty cząsteczek czynnika VIII
PL2411503T3 (pl) * 2009-03-27 2018-01-31 Eidgenoessische Technische Hochschule Zuerich Salmonella enterica prezentująca n-glikan z c. jejuni lub jego pochodne
NO2501406T3 (https=) 2009-11-19 2018-05-19
PT2545081E (pt) * 2010-02-11 2015-05-18 Univ Alberta Compostos de glicano ligados por n
US8841099B2 (en) * 2010-04-20 2014-09-23 National Research Council Of Canada Cell-based production of nonulosonates
EP3281639B1 (en) 2010-05-06 2020-11-11 GlaxoSmithKline Biologicals S.A. Capsular gram-positive bacteria bioconjugate vaccines
US9308246B2 (en) 2010-05-28 2016-04-12 The United States Of America As Represented By The Secretary Of The Navy Capsule composition for use as immunogen against Campylobacter jejuni
JP6135046B2 (ja) * 2012-04-20 2017-05-31 株式会社島津製作所 糖ペプチドの質量分析法
RU2671473C2 (ru) 2013-04-05 2018-10-31 Де Гавенерс Оф Де Юниверсити Оф Альберта Вакцина против кампилобактериоза
HK1246600B (en) * 2015-01-26 2020-04-09 Cadena Bio, Inc. Oligosaccharide compositions for use animal feed and methods of producing thereof
WO2017117539A1 (en) 2015-12-30 2017-07-06 Northwestern University Cell-free glycoprotein synthesis (cfgps) in prokaryotic cell lysates enriched with components for glycosylation
US10829795B2 (en) 2016-07-14 2020-11-10 Northwestern University Method for rapid in vitro synthesis of glycoproteins via recombinant production of N-glycosylated proteins in prokaryotic cell lysates
WO2019035916A1 (en) 2017-08-15 2019-02-21 Northwestern University DESIGN OF PROTEIN GLYCOSYLATION SITES BY RAPID EXPRESSION AND CHARACTERIZATION OF N-GLYCOSYLTRANSFERASES
EP3727437A4 (en) * 2017-12-19 2021-09-08 The Governors of the University of Alberta SURFACE GLYCANES OF CLOSTRIDIUM PERFRINGENS AND ASSOCIATED USES
US11530432B2 (en) 2018-03-19 2022-12-20 Northwestern University Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro via production and N-glycosylation of protein carriers in detoxified prokaryotic cell lysates
WO2019204346A1 (en) 2018-04-16 2019-10-24 Northwestern University METHODS FOR CO-ACTIVATING IN VITRO NON-STANDARD AMINO ACID (nsAA) INCORPORATION AND GLYCOSYLATION IN CRUDE CELLLYSATES
US12098433B2 (en) 2018-08-03 2024-09-24 Northwestern University On demand, portable, cell-free molecular sensing platform
CN113646438A (zh) 2019-01-11 2021-11-12 西北大学 在原核生物细胞裂解物中合成生物缀合物疫苗
US12325884B2 (en) 2019-03-04 2025-06-10 Northwestern University Riboswitch-based fluoride sensing in cell-free extract
US12226410B2 (en) 2019-10-18 2025-02-18 Northwestern University Methods for enhancing cellular clearance of pathological molecules via activation of the cellular protein ykt6
CN115135771A (zh) 2019-10-25 2022-09-30 西北大学 用于富集膜泡和增加糖蛋白产量的无细胞提取物制备方案
WO2022256920A1 (en) * 2021-06-07 2022-12-15 The University Of British Columbia Acholetin biopolymers and methods for enzymatic synthesis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925796A (en) * 1986-03-07 1990-05-15 Massachusetts Institute Of Technology Method for enhancing glycoprotein stability
US5200344A (en) * 1990-11-13 1993-04-06 Blaser Martin J Diagnostic testing for campylobacter jejuni or campylobacter coli infections using novel antigens
JPH09502604A (ja) * 1993-08-27 1997-03-18 エンテリック リサーチ ラボラトリーズ インコーポレイテッド Campylobacterjejuni抗原、並びにそれらの製造及び利用
ATE195147T1 (de) * 1994-09-06 2000-08-15 Ab Bioflexin Aminosäuren konjugaten
US5840547A (en) * 1995-01-05 1998-11-24 Ramot University Authority For Applied Research & Indfustrial Development Ltd. Bioemulsifiers
US6676946B2 (en) * 1997-03-27 2004-01-13 Institut Pasteur Multiple antigen glycopeptide carbohydrate vaccine comprising the same and use thereof
US6699705B2 (en) * 1999-02-01 2004-03-02 National Research Council Of Canada Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics
AU3513500A (en) * 1999-03-05 2000-09-21 Trustees Of Tufts College Emulsan and emulsan analogs immunization formulations and use
US6512014B2 (en) * 2000-12-13 2003-01-28 Ramot University Authority For Applied Research And Industrial Development Limited Compositions containing bioemulsifiers and a method for their preparation
ES2411007T3 (es) * 2001-10-10 2013-07-04 Novo Nordisk A/S Remodelación y glicoconjugación de péptidos
US20030232401A1 (en) * 2002-06-12 2003-12-18 Pugia Michael J. Bacterial test method by glycated label binding
AU2006295017B2 (en) * 2005-09-21 2010-06-17 The United States Of America As Represented By The Secretary Of The Navy Immunogenic capsule composition for use as a vaccine component against Campylobacter jejuni

Similar Documents

Publication Publication Date Title
JP2005534752A5 (https=)
CA2494223A1 (en) Campylobacter glycans and glycopeptides
Lee et al. Causative agents and epidemiology of diarrhea in Korean native calves
Leitner et al. Development of a Staphylococcus aureus vaccine against mastitis in dairy cows. II. Field trial
Zhao et al. Immersion vaccination of Mandarin fish Siniperca chuatsi against infectious spleen and kidney necrosis virus with a SWCNTs-based subunit vaccine
Muscatello Rhodococcus equi pneumonia in the foal–part 2: diagnostics, treatment and disease management
US8246963B2 (en) Vaccine for Edwardsiella disease and streptococcal disease in fish
PH12015501888B1 (en) Novel bacteriophage and antibacterial composition comprising the same
TNSN03154A1 (fr) Vaccin a mycoplasma bovis et methodes pour reduire la pneumonie chez des animaux.
ES2527470T3 (es) Composición farmacéutica que comprende un inhibidor de la bomba de protones y un prebiótico para el tratamiento de lesiones ulcerosas del estómago y el duodeno
CA2257826A1 (en) Helicobacter pylori adhesin binding group antigen
CN102139103B (zh) 半滑舌鳎美人鱼发光杆菌疫苗的制备与使用方法
TWI433651B (zh) 新穎乳酸菌株、含彼之組合物及其用途
Sombe et al. Optimization and field trial of an Aeromonas hydrophila vaccine candidate for motile Aeromonads septicemia in farmed Nile tilapia in Tanzania
CN101002947B (zh) 一种用于细菌病治疗的靶向药物及其制备方法
JP2006525981A (ja) アリシン
CN113908121A (zh) 一种氯硝柳胺注射液及其制备和应用
RU2352344C2 (ru) Способ профилактики эндометритов коров
RU2425148C2 (ru) Штамм brucella abortus уф-1 для приготовления биологических препаратов для диагностики и специфической профилактики бруцеллеза сельскохозяйственных животных
CN109913391B (zh) 罗非鱼源海豚链球菌弱毒株及应用
JP7021283B2 (ja) 魚類の連鎖球菌病予防用新規血清型ワクチン
CN116555081A (zh) 猪链球菌菌株及防治猪链球菌病的多价疫苗及其应用
Tarello et al. Corynebacterium pseudotuberculosis and Corynebacterium renale isolated from two Arabian oryx (Oryx leucoryx)
RU2179846C2 (ru) Средство для профилактики и лечения желудочно-кишечных и респираторных заболеваний телят
CN101780266A (zh) 防治畜禽呼吸道疾病的复方制剂